How much did Astec Lifesciences achieve in EBIT for the current year?
In the current year, Astec Lifesciences has achieved an EBIT of -420.55 M INR.
Astec Lifesciences EBIT 2024
Astec Lifesciences EBIT
-420.55 M INR
Ticker
ASTEC.NS
ISIN
INE563J01010
In 2024, Astec Lifesciences's EBIT was -420.55 M INR, a -197.52% increase from the 431.25 M INR EBIT recorded in the previous year.
The Astec Lifesciences EBIT history
| YEAR | EBIT (undefined INR) |
|---|---|
| 2027e | 1.41 |
| 2026e | 1.23 |
| 2025e | 0.39 |
| 2024 | -0.42 |
| 2023 | 0.43 |
| 2022 | 1.2 |
| 2021 | 0.86 |
| 2020 | 0.62 |
| 2019 | 0.57 |
| 2018 | 0.54 |
| 2017 | 0.49 |
| 2016 | 0.21 |
| 2015 | 0.42 |
| 2014 | 0.21 |
| 2013 | 0.17 |
| 2012 | 0.09 |
| 2011 | 0.1 |
| 2010 | 0.21 |
| 2009 | 0.18 |
| 2008 | 0.13 |
| 2007 | 0.05 |
| 2006 | 0.04 |
| 2005 | 0.02 |
Astec Lifesciences Revenue, EBIT, Net Income INE563J01010 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Astec Lifesciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Astec Lifesciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Astec Lifesciences’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Astec Lifesciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Astec Lifesciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Astec Lifesciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Astec Lifesciences’s growth potential.
Astec Lifesciences Revenue, EBIT and net profit per share
| Date | Astec Lifesciences Revenue | Astec Lifesciences EBIT | Astec Lifesciences Net Income |
|---|---|---|---|
| 2027e | 9.92 B INR | 1.41 B INR | 967.11 M INR |
| 2026e | 8.1 B INR | 1.23 B INR | 816.01 M INR |
| 2025e | 6.57 B INR | 389.34 M INR | 165.63 M INR |
| 2024 | 4.58 B INR | -420.55 M INR | -469.3 M INR |
| 2023 | 6.28 B INR | 431.25 M INR | 255.65 M INR |
| 2022 | 6.77 B INR | 1.2 B INR | 898.6 M INR |
| 2021 | 5.55 B INR | 859.2 M INR | 650.5 M INR |
| 2020 | 5.23 B INR | 621.9 M INR | 475.1 M INR |
| 2019 | 4.31 B INR | 571.6 M INR | 357.4 M INR |
| 2018 | 3.71 B INR | 541.3 M INR | 349 M INR |
| 2017 | 3.13 B INR | 489.5 M INR | 191.2 M INR |
| 2016 | 2.47 B INR | 211.7 M INR | 49.7 M INR |
| 2015 | 2.67 B INR | 415 M INR | 147.8 M INR |
| 2014 | 2.07 B INR | 206 M INR | 86.8 M INR |
| 2013 | 1.75 B INR | 173.9 M INR | 60.2 M INR |
| 2012 | 1.13 B INR | 86.6 M INR | 13.7 M INR |
| 2011 | 1.1 B INR | 100.7 M INR | 49 M INR |
| 2010 | 1.16 B INR | 212.5 M INR | 132.1 M INR |
| 2009 | 844.1 M INR | 179.9 M INR | 107.3 M INR |
| 2008 | 550.9 M INR | 132.7 M INR | 79.4 M INR |
| 2007 | 314.7 M INR | 50.8 M INR | 37 M INR |
| 2006 | 252.8 M INR | 44.7 M INR | 34.8 M INR |
| 2005 | 211.1 M INR | 21.7 M INR | 14.1 M INR |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2005 | 211.1 M INR | 21.7 M INR | 14.1 M INR |
| 2006 | 252.8 M INR | 44.7 M INR | 34.8 M INR |
| 2007 | 314.7 M INR | 50.8 M INR | 37 M INR |
| 2008 | 550.9 M INR | 132.7 M INR | 79.4 M INR |
| 2009 | 844.1 M INR | 179.9 M INR | 107.3 M INR |
| 2010 | 1.16 B INR | 212.5 M INR | 132.1 M INR |
| 2011 | 1.1 B INR | 100.7 M INR | 49 M INR |
| 2012 | 1.13 B INR | 86.6 M INR | 13.7 M INR |
| 2013 | 1.75 B INR | 173.9 M INR | 60.2 M INR |
| 2014 | 2.07 B INR | 206 M INR | 86.8 M INR |
| 2015 | 2.67 B INR | 415 M INR | 147.8 M INR |
| 2016 | 2.47 B INR | 211.7 M INR | 49.7 M INR |
| 2017 | 3.13 B INR | 489.5 M INR | 191.2 M INR |
| 2018 | 3.71 B INR | 541.3 M INR | 349 M INR |
| 2019 | 4.31 B INR | 571.6 M INR | 357.4 M INR |
| 2020 | 5.23 B INR | 621.9 M INR | 475.1 M INR |
| 2021 | 5.55 B INR | 859.2 M INR | 650.5 M INR |
| 2022 | 6.77 B INR | 1.2 B INR | 898.6 M INR |
| 2023 | 6.28 B INR | 431.25 M INR | 255.65 M INR |
| 2024 | 4.58 B INR | -420.55 M INR | -469.3 M INR |
| 2025e | 6.57 B INR | 389.34 M INR | 165.63 M INR |
| 2026e | 8.1 B INR | 1.23 B INR | 816.01 M INR |
| 2027e | 9.92 B INR | 1.41 B INR | 967.11 M INR |
Astec Lifesciences stock margins INE563J01010 ·
The Astec Lifesciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Astec Lifesciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Astec Lifesciences.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Astec Lifesciences's sales revenue. A higher gross margin percentage indicates that the Astec Lifesciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Astec Lifesciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Astec Lifesciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Astec Lifesciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Astec Lifesciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Astec Lifesciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Astec Lifesciences Margin History
| Astec Lifesciences Gross margin | Astec Lifesciences Profit margin | Astec Lifesciences EBIT margin | Astec Lifesciences Profit margin |
|---|---|---|---|
| 2027e | 21.03 % | 14.23 % | 9.75 % |
| 2026e | 21.03 % | 15.21 % | 10.07 % |
| 2025e | 21.03 % | 5.92 % | 2.52 % |
| 2024 | 21.03 % | -9.18 % | -10.24 % |
| 2023 | 26.99 % | 6.87 % | 4.07 % |
| 2022 | 35.01 % | 17.7 % | 13.28 % |
| 2021 | 32.09 % | 15.48 % | 11.72 % |
| 2020 | 28.23 % | 11.9 % | 9.09 % |
| 2019 | 28.71 % | 13.27 % | 8.29 % |
| 2018 | 29.46 % | 14.6 % | 9.41 % |
| 2017 | 31.93 % | 15.62 % | 6.1 % |
| 2016 | 34.84 % | 8.57 % | 2.01 % |
| 2015 | 33.03 % | 15.55 % | 5.54 % |
| 2014 | 29.65 % | 9.95 % | 4.19 % |
| 2013 | 29.71 % | 9.95 % | 3.45 % |
| 2012 | 26.25 % | 7.67 % | 1.21 % |
| 2011 | 22.94 % | 9.19 % | 4.47 % |
| 2010 | 27.79 % | 18.24 % | 11.34 % |
| 2009 | 36.67 % | 21.31 % | 12.71 % |
| 2008 | 43.15 % | 24.09 % | 14.41 % |
| 2007 | 35.97 % | 16.14 % | 11.76 % |
| 2006 | 35.32 % | 17.68 % | 13.77 % |
| 2005 | 30.55 % | 10.28 % | 6.68 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2005 | 30.55 % | 10.28 % | 6.68 % |
| 2006 | 35.32 % | 17.68 % | 13.77 % |
| 2007 | 35.97 % | 16.14 % | 11.76 % |
| 2008 | 43.15 % | 24.09 % | 14.41 % |
| 2009 | 36.67 % | 21.31 % | 12.71 % |
| 2010 | 27.79 % | 18.24 % | 11.34 % |
| 2011 | 22.94 % | 9.19 % | 4.47 % |
| 2012 | 26.25 % | 7.67 % | 1.21 % |
| 2013 | 29.71 % | 9.95 % | 3.45 % |
| 2014 | 29.65 % | 9.95 % | 4.19 % |
| 2015 | 33.03 % | 15.55 % | 5.54 % |
| 2016 | 34.84 % | 8.57 % | 2.01 % |
| 2017 | 31.93 % | 15.62 % | 6.1 % |
| 2018 | 29.46 % | 14.6 % | 9.41 % |
| 2019 | 28.71 % | 13.27 % | 8.29 % |
| 2020 | 28.23 % | 11.9 % | 9.09 % |
| 2021 | 32.09 % | 15.48 % | 11.72 % |
| 2022 | 35.01 % | 17.7 % | 13.28 % |
| 2023 | 26.99 % | 6.87 % | 4.07 % |
| 2024 | 21.03 % | -9.18 % | -10.24 % |
| 2025e | 21.03 % | 5.92 % | 2.52 % |
| 2026e | 21.03 % | 15.21 % | 10.07 % |
| 2027e | 21.03 % | 14.23 % | 9.75 % |
Astec Lifesciences Aktienanalyse
What does Astec Lifesciences do?
Astec Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Astec Lifesciences's EBIT
Astec Lifesciences's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Astec Lifesciences's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Astec Lifesciences's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Astec Lifesciences’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Astec Lifesciences stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Astec Lifesciences.
How has the EBIT of Astec Lifesciences developed in recent years?
The EBIT of Astec Lifesciences has increased by -197.518% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Astec Lifesciences?
The EBIT of Astec Lifesciences is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Astec Lifesciences pay?
Over the past 12 months, Astec Lifesciences paid a dividend of 1.5 INR . This corresponds to a dividend yield of about 0.14 %. For the coming 12 months, Astec Lifesciences is expected to pay a dividend of 0.34 INR.
What is the dividend yield of Astec Lifesciences?
The current dividend yield of Astec Lifesciences is 0.14 %.
When does Astec Lifesciences pay dividends?
Astec Lifesciences pays a quarterly dividend. This is distributed in the months of August, August, August, August.
How secure is the dividend of Astec Lifesciences?
Astec Lifesciences paid dividends every year for the past 3 years.
What is the dividend of Astec Lifesciences?
For the upcoming 12 months, dividends amounting to 0.34 INR are expected. This corresponds to a dividend yield of 0.03 %.
In which sector is Astec Lifesciences located?
Astec Lifesciences is assigned to the 'Commodities' sector.
Wann musste ich die Aktien von Astec Lifesciences kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Astec Lifesciences from 8/1/2023 amounting to 1.5 INR, you needed to have the stock in your portfolio before the ex-date on 7/21/2023.
When did Astec Lifesciences pay the last dividend?
The last dividend was paid out on 8/1/2023.
What was the dividend of Astec Lifesciences in the year 2023?
In the year 2023, Astec Lifesciences distributed 1.5 INR as dividends.
In which currency does Astec Lifesciences pay out the dividend?
The dividends of Astec Lifesciences are distributed in INR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Astec Lifesciences
Our stock analysis for Astec Lifesciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Astec Lifesciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Astec Lifesciences Revenue
- Astec Lifesciences Net Income
- Astec Lifesciences P/E
- Astec Lifesciences P/S
- Astec Lifesciences EBIT
- Astec Lifesciences Dividend
- Astec Lifesciences Stocks
- Astec Lifesciences Market capitalization
- Astec Lifesciences Debt
- Astec Lifesciences Liabilities
- Astec Lifesciences Equity
- Astec Lifesciences AAQS
- Astec Lifesciences Employees
- Astec Lifesciences ROE
- Astec Lifesciences ROA
- Astec Lifesciences ROCE